ZA943610B - Oligopeptides derived from c-reactive protein fragments - Google Patents

Oligopeptides derived from c-reactive protein fragments

Info

Publication number
ZA943610B
ZA943610B ZA943610A ZA943610A ZA943610B ZA 943610 B ZA943610 B ZA 943610B ZA 943610 A ZA943610 A ZA 943610A ZA 943610 A ZA943610 A ZA 943610A ZA 943610 B ZA943610 B ZA 943610B
Authority
ZA
South Africa
Prior art keywords
pct
reactive protein
protein fragments
oligopeptides derived
derived
Prior art date
Application number
ZA943610A
Other languages
English (en)
Inventor
Patrizia Caretto
Fabrizio Marcucci
Paolo Mascagni
Silvana Cappelletti
Flavio Leoni
Gianni Gromo
Massimo Pinori
Original Assignee
Italfamaco S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfamaco S P A filed Critical Italfamaco S P A
Publication of ZA943610B publication Critical patent/ZA943610B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA943610A 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments ZA943610B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Publications (1)

Publication Number Publication Date
ZA943610B true ZA943610B (en) 1995-01-25

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943610A ZA943610B (en) 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments

Country Status (19)

Country Link
US (1) US6057295A (de)
EP (1) EP0723552B1 (de)
JP (1) JP3221881B2 (de)
KR (1) KR100363408B1 (de)
CN (1) CN1041524C (de)
AT (1) ATE226591T1 (de)
AU (1) AU684511B2 (de)
CA (1) CA2173939C (de)
DE (1) DE69431603T2 (de)
DK (1) DK0723552T3 (de)
ES (1) ES2185652T3 (de)
FI (1) FI961584A (de)
HU (1) HUT75538A (de)
IL (1) IL109761A0 (de)
IT (1) IT1271486B (de)
NO (1) NO961423L (de)
PT (1) PT723552E (de)
WO (1) WO1995010531A1 (de)
ZA (1) ZA943610B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (de) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidinderivate zur Behandlung von Hepatitis C Virusinfektion
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
WO2011090954A2 (en) 2010-01-19 2011-07-28 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
EP2734843A2 (de) 2011-07-18 2014-05-28 President and Fellows of Harvard College Manipulierte moleküle zur anzielung von mikroben und ihre verwendungen
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3848045A1 (de) 2013-05-21 2021-07-14 President and Fellows of Harvard College Manipulierte hämbindende zusammensetzungen und verwendungen davon
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
KR100363408B1 (ko) 2003-02-11
HUT75538A (en) 1997-05-28
IT1271486B (it) 1997-05-28
FI961584A0 (fi) 1996-04-11
NO961423D0 (no) 1996-04-11
CN1041524C (zh) 1999-01-06
ATE226591T1 (de) 2002-11-15
DE69431603D1 (de) 2002-11-28
CN1133048A (zh) 1996-10-09
JPH09503200A (ja) 1997-03-31
IL109761A0 (en) 1994-08-26
CA2173939A1 (en) 1995-04-20
ITMI932154A0 (it) 1993-10-12
HU9600934D0 (en) 1996-08-28
DK0723552T3 (da) 2003-02-24
US6057295A (en) 2000-05-02
AU684511B2 (en) 1997-12-18
WO1995010531A1 (en) 1995-04-20
CA2173939C (en) 2002-08-27
ITMI932154A1 (it) 1995-04-12
EP0723552A1 (de) 1996-07-31
DE69431603T2 (de) 2003-03-13
ES2185652T3 (es) 2003-05-01
NO961423L (no) 1996-06-10
JP3221881B2 (ja) 2001-10-22
FI961584A (fi) 1996-04-11
EP0723552B1 (de) 2002-10-23
PT723552E (pt) 2003-02-28
AU6844194A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
EP2270046A3 (de) Verfahren und Zusammensetzungen zur Behandlung von mit Hämolyse assoziierten Krankheiten
WO1998026747A3 (en) Superantigen based methods and compositions for treatment of diseases
HK1030625A1 (en) Methods and compositions for immunomodulation
EP0687183A4 (de) Synergistische zusammensetzung bestehend aus einem auf cd4-basierendem protein und anti-hiv-1-antikörper, und methoden zu deren verwendung
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
EP1642506A3 (de) verwendung von äurestabilen subtilisinproteasen in tierfutter
GB2288732B (en) Pharmaceutical compositions
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
WO1996017935A3 (en) Rantes peptide and fragments and compositions comprising it for treatment of inflammation
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
WO1996007738A3 (en) Modified human c3 proteins
IL109761A0 (en) Oligopeptides derived from c-reactive protein fragments
AU1384995A (en) Human circulating cytokine cc-1
EP1364657A4 (de) Mittel gegen tumoren in hämatopoetischen organen
DE69534753D1 (de) Nierenpolycystose-gen
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
HUP0000812A3 (en) Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
GB9723824D0 (en) Cytostatic agents
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
AU1879097A (en) Fragments of cr1 and their use
EP1671646A3 (de) Verfahren zur Behandlung von IgE- assoziierten Krankheiten und Zusammensetzungen zur Verwendung in diesen Verfahren